September 09, 2021
COVID-19 has highlighted the vital importance of clinical trials for drug and vaccine development, but it has also forced companies to completely redesign how these trials are run. With the pandemic creating appetite for the wider adoption of virtualisation technologies, it’s critical for the future success and development of the clinical trial sector to decentralise components of the process...